articleTop 1% cited

Toll-like receptor 9–dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE

Nature Immunology · 2007 · Vol. 8(5) · pp. 487–496

Jane Tian✉Ana M. Avalos(Boston University)Su-Yau MaoBo ChenKannaki SenthilHerren WuPeggy Parroche(University of Massachusetts Chan Medical School)Stacey DrabicDouglas T. Golenbock(University of Massachusetts Chan Medical School)Cherilyn M. Sirois(University of Massachusetts Chan Medical School)Jing Hua(Hospital for Special Surgery)Ling AnLaurent AudolyGreg La RosaAngelika Bierhaus(Heidelberg University)Peter Naworth(Heidelberg University)Ann Marshak‐Rothstein(Boston University)Mary K. Crow(Hospital for Special Surgery)Katherine A. Fitzgerald(University of Massachusetts Chan Medical School)Eicke Latz(University of Massachusetts Chan Medical School)Peter A. KienerAnthony J. Coyle

View via DOI Publisher page

Advanced Glycation End Products research Immune Response and Inflammation Immunotherapy and Immune ResponsesTLR9HMGB1Rage (emotion)Toll-Like Receptor 9Immune systemToll-like receptorCytokineReceptorImmunologyBiology

MeSH terms

Receptor for Advanced Glycation End ProductsAnimalsAntigen-Antibody ComplexB-LymphocytesDendritic CellsDNA-Binding ProteinsLupus Erythematosus, SystemicMice, Inbred C57BLOligodeoxyribonucleotidesReceptors, Cell SurfaceCpG IslandsHMGB1 ProteinToll-Like Receptor 9Mice

Citations

1,340

FWCI

66.44

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Mechanisms of Diabetic Complications